Suppliers / Corden Pharma

Corden Pharma

Italy 3 duplicate records merged Updated 9 July 2026

The public registers hold a second record for Corden Pharma. The fuller profile, with 17 active US DMFs and 3 valid CEPs, is at Corden Pharma. Figures on this page cover only this record.

Corden Pharma is a finished-dose manufacturer based in Italy. It holds one active US drug master file. Its filings concentrate with US FDA, MINSA (CR) and ARCSA (EC). Its GMP standing is certified by EMA, ZLG (DE) and US FDA. Its most recent recorded inspection, by US FDA, closed on 14 June 2024 as VAI. Customs aggregates show $37K of exports covering 10 molecules to 1 destination in 2022.

1
active US DMFs
0
valid CEPs
7
registered plants 2 with an FDA FEI number
24
filings across 9 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
2 of 2 confirmed
Inspections
4 of 4 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 14 June 2024 VAI US FDA
  • 2 November 2018 NAI US FDA
  • 31 January 2014 NAI US FDA
  • 22 December 2011 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Plankstadt, United Arab Emirates Not on file
Caponago, United Arab Emirates Not on file
Switzerland, Switzerland 3002561809
Frankfurt, Germany Not on file
Germany, Germany 3012722976
CAPONAGO, Italy Not on file

1 further sites are on record.

What they file, and where

Molecule Regulators Docs
1 US FDA 1

Also appears on these molecule pages

Carboplatin finished dose Cefprozil finished dose Etoposide finished dose Propofol finished dose Racecadotril finished dose

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA 8 1
MINSA (CR) 4 None
ARCSA (EC) 3 None
NAFDAC (NG) 2 None
INVIMA (CO) 2 None
DIGEMAPS (DO) 2 None
EMA None 4
ZLG (DE) None 4

Scale

Year Revenue Exports Destinations
2022 Not reported $37K 1

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Corden Pharma

Does Corden Pharma hold a US DMF or a CEP?
Corden Pharma holds 1 active US drug master file. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Corden Pharma FDA-registered?
2 sites operated by Corden Pharma carry an FDA establishment identifier (FEI), which means they are registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Corden Pharma's last inspection go?
The most recent inspection on record closed on 14 June 2024 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 4 inspections are on file.
Where does Corden Pharma manufacture?
7 registered sites are on record, in United Arab Emirates, Switzerland, Germany and Italy (Plankstadt, Caponago and Switzerland among others). Every site is listed on this page with the register it came from.
What does Corden Pharma make?
1 molecule is on record against Corden Pharma, including 1. Each links through to that molecule's full manufacturer list.
Which regulators recognise Corden Pharma's GMP?
Current GMP certificates are on record from EMA, ZLG (DE) and US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Corden Pharma comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 14 June 2024.

Comparable suppliers

Angelini Pharma also in Italy Biofer also in Italy Adare Pharmaceuticals also in Italy Amsa Anonima Materie Sintetiche And Affini also in Italy Bracco Imaging also in Italy

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts